Home › Bleeding › District of Columbia › Washington
Bleeding clinical trials in Washington, DC
4 studies for Bleeding are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
- American Oncology Partners of Maryland, PA, Bethesda · 7 mi away
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
RecruitingPhase 3
- Georgetown University, Washington D.C.
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RecruitingPhase 3
- MedStar Washington Hospital Center, Washington D.C.
About Bleeding
Bleeding is the loss of blood, inside or outside the body. A hemorrhage is severe bleeding. Learn about the causes of bleeding and how to treat it.
More about Bleeding on MedlinePlus
Bleeding trials in other cities
- Boston, MA10 studies
- New York City, NY8 studies
- Houston, TX7 studies
- Atlanta, GA6 studies
- Cleveland, OH6 studies
- Chicago, IL6 studies
- Seattle, WA5 studies
- Durham, NC5 studies
- Indianapolis, IN5 studies
- Philadelphia, PA5 studies
- St. Louis, MO5 studies
- San Diego, CA4 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease29 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Lymphoma23 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.